APA
Doherty M. K., O'Connor E., Hannon D., O'Reilly A., Yen D., Redmond M., Grogan L. M., Hennessy B. T., Breathnach O. S. & Morris P. G. (20190322). Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy. : Irish journal of medical science.
Chicago
Doherty Mark K, O'Connor Emer, Hannon David, O'Reilly Aine, Yen Daphne, Redmond Maeve, Grogan Liam M, Hennessy Bryan T, Breathnach Oscar S and Morris Patrick G. 20190322. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy. : Irish journal of medical science.
Harvard
Doherty M. K., O'Connor E., Hannon D., O'Reilly A., Yen D., Redmond M., Grogan L. M., Hennessy B. T., Breathnach O. S. and Morris P. G. (20190322). Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy. : Irish journal of medical science.
MLA
Doherty Mark K, O'Connor Emer, Hannon David, O'Reilly Aine, Yen Daphne, Redmond Maeve, Grogan Liam M, Hennessy Bryan T, Breathnach Oscar S and Morris Patrick G. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy. : Irish journal of medical science. 20190322.